Chemotherapeutic strategies for advanced breast cancer

Susanne Briest, Vered Stearns

Research output: Contribution to journalReview articlepeer-review

Abstract

Disease-free and overall survival have improved significantly for women diagnosed with early-stage breast cancer. At the same time, systemic therapy has only slightly enhanced long-term outcomes in advanced breast cancer, a disease that remains largely incurable. Several single-agent and combination chemotherapy approaches are available to women with hormone-insensitive advanced disease that may improve overall survival and progression-free survival, minimize symptoms and complications related to the disease, and improve over-all quality of life. In addition, new cytotoxic and targeted agents have been recently introduced into practice and have improved both survival outcomes and quality of life. In this review, we will provide an update on commonly used chemotherapy-based regimens for the treatment of metastatic breast cancer, with a focus on tailoring therapy to different subtypes of the disease.

Original languageEnglish (US)
Pages (from-to)1325-1335
Number of pages11
JournalONCOLOGY
Volume21
Issue number11
StatePublished - Oct 1 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Chemotherapeutic strategies for advanced breast cancer'. Together they form a unique fingerprint.

Cite this